Status:
COMPLETED
A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This study will look at whether this new drug is effective in the treatment of rheumatoid arthritis, and at whether it is safe and well-tolerated by participants with the disease.
Eligibility Criteria
Inclusion
- Rheumatoid arthritis, according to the American College of Rheumatology criteria, with active disease despite current medications
- Other criteria also apply
Exclusion
- Other major illnesses
- Past history of certain other disorders
- Certain prohibited medications
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2005
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT00132769
Start Date
January 1 2005
End Date
November 1 2005
Last Update
July 30 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.